Follow The Filings

PROF Profound Medical Corporation

Health Care, filed as PROFOUND MED CORP (COM NEW), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 2 Owners
  • Max 0.3%
  • $4.7M
  • 1 add 1 small

In 2026 Q2 First Eagle Investment Management added to Profound Medical.

Who owns this now

Largest portfolio weights among holders, up to 0.3% (Nathan Fischel, Dafna Capital Management). Not free-float ownership.

  1. Nathan Fischel Reduce 0.33%

Who owns PROF

Sorted by value, long equity only, as of 2026 Q2.

History
First Eagle Investment Management <0.01% Add +36.4% 440,207 $2.9M History
Nathan Fischel, Dafna Capital Management 0.33%, was 0.39% Small trim −1.0% 260,360 $1.7M History

2 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.07,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated about 8 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2024 FY2025
Revenue $9.74M —
Gross profit $7.04M $11.39M
Gross margin * 72.2% —
Net income -$27.82M -$42.57M
Net margin * -285.6% —

Balance sheet

Metric FY2024 FY2025
Total current assets $69.06M $76.09M
Total non-current assets * $1.17M $1.39M
Total assets $70.23M $77.48M
Total current liabilities $6.56M $6.08M
Total non-current liabilities * $3.25M $4.97M
Total equity $60.42M $66.43M

Cash flow

Metric FY2024 FY2025
Cash from operations -$23.45M -$38.21M
Cash from investing — -$242,000
Cash from financing $54.7M $41.14M
Net change in cash * — $2.69M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.